Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth (Q35754279)

10 August 2017

Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth (English)

1 reference

10 August 2017

1 reference

Xinhai Wan

1

1 reference

10 August 2017

Zhi-Gang Li

2

1 reference

10 August 2017

Jonathan M Yingling

3

1 reference

10 August 2017

Jun Yang

4

1 reference

10 August 2017

Michael W Starbuck

5

1 reference

10 August 2017

Murali K Ravoori

6

1 reference

10 August 2017

Vikas Kundra

7

1 reference

10 August 2017

Elba Vazquez

8

1 reference

10 August 2017

Nora M Navone

9

1 reference

10 August 2017

7 December 2011

1 reference

10 August 2017

1 reference

10 August 2017

50

1 reference

10 August 2017

3

1 reference

10 August 2017

695-703

1 reference

Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-β in cancer and bone: implications for treatment of bone metastases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGFbeta signalling: a complex web in cancer progression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Cancer treatment-induced bone loss in breast and prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-beta regulates the mechanical properties and composition of bone matrix

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Specificity and versatility in tgf-beta signaling through Smads

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Transforming growth factor-beta1 to the bone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Development of TGF-beta signalling inhibitors for cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-beta signaling: positive and negative effects on tumorigenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Establishment of two human prostate cancer cell lines derived from a single bone metastasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278589

Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173053

12 December 2020

inferred from PubMed ID database lookup

Early Postoperative Plasma Transforming Growth Factor-β1 is a Strong Predictor of Biochemical Progression After Radical Prostatectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173053

12 December 2020

inferred from PubMed ID database lookup

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173053

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.BONE.2011.11.022

1 reference

release_mwic4oqmbjfldndo6nluvl3rga

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mwic4oqmbjfldndo6nluvl3rga

24 November 2022

mapped directly with Wikidata item

PMCID

3278589

1 reference

10 August 2017

1 reference